![Miles Harrison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Miles Harrison
Chief Executive Officer at
CONEXEU SCIENCES INC.
Net worth: 4 M $ as of 31/05/2026
Profile
Miles D.
Harrison is the founder of Novaestiq Corp.
Currently, Mr. Harrison is President, Chief Executive Officer & Director at Conexeu Sciences, Inc. since 2025 and Independent Director at Castle Biosciences, Inc. since 2020.
Formerly, Mr. Harrison was President & CEO-North America Region at Galderma Laboratories LP from 2016 to 2021.
Education includes an undergraduate degree from Sheffield Hallam University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/05/2026 | 2,37,861 ( 0.94% ) | 3 M $ | 31/05/2026 | |
| 28/05/2026 | 35,631 ( 0.12% ) | 751 101 $ | 31/05/2026 |
Miles Harrison active positions
| Companies | Position | Start |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Director/Board Member | 01/04/2020 |
| CONEXEU SCIENCES INC. | Chief Executive Officer | 23/10/2025 |
Former positions of Miles Harrison
| Companies | Position | End |
|---|---|---|
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Corporate Officer/Principal | 01/01/2021 |
Novaestiq Corp.
 Novaestiq Corp. Household/Personal CareConsumer Non-Durables Develops aesthetic products for skin care | Chief Executive Officer | - |
Training of Miles Harrison
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Castle Biosciences, Inc.
 Castle Biosciences, Inc. Medical SpecialtiesHealth Technology Operates dermatological cancer company which provides clinically actionable genomic information to make accurate treatment decisions | Health Technology |
Sheffield Hallam University
 Sheffield Hallam University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Health Technology |
Novaestiq Corp.
Novaestiq Corp. Household/Personal CareConsumer Non-Durables Develops aesthetic products for skin care | Consumer Non-Durables |
CONEXEU SCIENCES INC.
 CONEXEU SCIENCES INC. BiotechnologyHealth Technology Operates as an early state medical technology company that develops and commercializes novel cellular therapies for skin restoration in wound care and aesthetics | Health Technology |
- Stock Market
- Insiders
- Miles Harrison
